Company / Book Value per Share
RECURSION PHARMACEUTICALS, INC. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.85
FY2025
5-year range
-$1.212 / $24.331
FY2021-FY2025
Trend
-35.5%
vs FY2024
Sector context
#139 of 209
Health Care
What the data says
At $2.85, RECURSION PHARMACEUTICALS, INC.'s book value per share ranks #139 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 7 years, ranging from -$9.471 in FY2020 to $24.331 in FY2021.
Based on SEC 10-K filings.
$2.85 in FY2025.
Improved from $2.426 to $2.85 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#139 of 209 in Health CareTop 67% of 209This company $2.85 Sector average $215.686
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, book value per share decreased 35.5% year-over-year.
- Ranks #139 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
- Lowest book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.85 | -35.5% |
| FY2024 | $4.417 | +82.1% |
| FY2023 | $2.426 | +300.3% |
| FY2022 | -$1.212 | -105.0% |
| FY2021 | $24.331 | +356.9% |
| FY2020 | -$9.471 | -64.4% |
| FY2019 | -$5.761 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026